A macromolecule includes i) a dendrimer comprising a core and at least one generation of building units, the outermost generation of building units having surface amino groups wherein at least two different terminal groups are covalently attached to the surface amino groups of the dendrimer, ii) a first terminal group which is a residue of a pharmaceutically active agent comprising a hydroxyl group, and iii) a second terminal group which is a pharmacokinetic modifying agent. The pharmaceutically active agent is cabazitaxel. The first terminal group is covalently attached to the surface amino group of the dendrimer through a diacid linker, the diacid linker comprising an alkyl chain interrupted by one or more oxygen, sulfur or nitrogen atoms, or a pharmaceutically acceptable salt thereof.

A method for producing a plated part, includes: forming, on a surface of a base member, a catalyst activity inhibiting layer containing a polymer which has at least one of an amide group and an amino group; irradiating with light or heating a part of the surface of the base member on which the catalyst activity inhibiting layer is formed; applying an electroless plating catalyst to the surface of the base member heated or irradiated with the light; and bringing an electroless plating solution into contact with the surface of the base member to which the electroless plating catalyst is applied, to form an electroless plating film at a light-irradiated portion or a heated portion of the surface.

Simple organic structures, organic/inorganic polymers, and other substrates have been made, all of which have at least one pyrrolidone moiety present, and found to exhibit low toxicity, low complement activation features and may be used to reduce protein interactions with drug conjugates while enhancing in vivo residency times for these conjugates when used as an injectable composition; thus these compounds can be used as substitutes for PEG in PEGylation. Surprisingly, these compounds also exhibit unique intrinsic fluorescence (IF) or non-traditional fluorescence (NTF) properties that currently cannot be explained by traditional photochemistry and fluorescence paradigms are described. These compounds have a variety of applications such as in cellular imaging, gene transfection, bio-diagnostics, biosensing, fluorescence directed surgical resections, drug delivery, forensics, environmental diagnostics, mineral/gemstone characterization, counterfeit goods detection, tracer studies related to liquid/water flow, oil field enhancements and diagnostics, prevention of photo-bleaching, and LED display enhancements and others.

The object of the present invention is to provide an aggregatable carrier material for drug delivery system and a micelle formed thereof. The present invention provides an aggregatable carrier material for drug delivery system, which is formed by utilizing the reaction between thiol group and alkyl halide. It is formed by using carbosilane dendrimers containing silole and labeled proteins such as green fluorescent protein in aqueous solvent or in mixed solvent of the aqueous solvent and organic solvent. The micelle composed of the material may incorporate compounds having a variety of molecular weight and biopolymers in the aqueous solvent.

The present invention relates to multi-arm surfactant-system thickening star macromolecules, and methods of preparing and using the same. In one aspect of the invention, a surfactant-system thickening star macromolecule is capable of providing surfactant-compatibility, increase the viscosity of a surfactant-containing system, and/or temperature-stability to an aqueous composition.

Dendrimeric metallacrowns may include a monomeric metallacrown complex or a dimeric metallacrown complex. In an example, the dendrimeric metallacrown includes the monomeric metallacrown complex and a dendron. In this example, the monomeric metallacrown complex includes a central ion, and a metallomacrocycle attached to the central ion. The central ion is selected from the group consisting of a lanthanide ion, a d-block transition metal ion or rare earth metal ion, and an s-block alkali or alkaline earth metal. The metallomacrocycle includes a repeating sub-unit consisting of a metal ion and a ring ligand selected from the group consisting of a hydroxamic acid derivative and an oxime derivative. The dendron is respectively attached to each of the ring ligands of the metallomacrocycle.

An ink is provided, which includes a resin, UV curable monomer, and photo initiator. The resin is formed by reacting a plurality of end capping agents with a dendrimer compound in an environment including esterification catalyst, inhibitor, and first solvent. The dendrimer compound is formed by reacting a multi-hydroxy compound and a plurality of hydroxy-containing epoxy compounds in an environment including alkaline catalyst and second solvent. The multi-hydroxy compound and the hydroxy-containing epoxy compounds have a molar ratio of 1:6 to 1:20, and the multi-hydroxy compound and the end capping agents have a molar ratio of 1:6 to 1:20. The end capping agents include acrylic acid, methacrylic acid, glycidyl methacrylate, or 2-amino acrylic acid. The resin and the UV curable monomer have a weight ratio of 100:30 to 100:5000, and the resin and the photo initiator have a weight ratio of 100:30 to 100:500.

Disclosed are dendrimers of formula (I):

##STR00001##

and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions comprising the dendrimer of formula (I) and methods of using the same for treating cancer.

The invention a fluorinated dendrimer and a preparation method thereof. The preparation method of the fluorinated dendrimer include the following steps: S1, obtaining an intermediate product by addition reaction of 4-fluoroaniline and methyl acrylate at room temperature; S2, stirring the intermediate product with 1,3-diamino-2-propanol and methyl acrylate at room temperature to obtain a mixture; S3, performing a stage heating reaction of the mixture under a reduced pressure condition to obtain the fluorinated dendrimer. The fluorinated dendrimer can solve the problems of high demulsification temperature, large dosage, and low demulsification efficiency of existing demulsifiers.

Oil soluble rheology modifying star macromolecules having a core and five or more polymeric arms, and compositions comprising the same. The polymeric arms on a star are covalently attached to the core of the star; each polymeric arm comprises one or more (co)polymer segments; and each polymeric arm comprises a monomeric unit of a methyl methacrylate. The oil soluble rheology modifying star macromolecules and compositions comprising the same for use in oil based systems.